HealthMicrobiome in Newborns
Lifelong Health Begins with a "Dirty" Gut
Peptides have gone from a niche corner of endocrinology to one of the most talked about topics in wellness. But, the hype doesn’t distinguish between a peptide with decades of rigorous human trials behind it vs. one with almost no human data at all. As someone who spends her days evaluating what actually works in a regimen, I wanted to walk through the most talked about peptides in plain language: what they are, what they claim to do, and how strong the evidence actually is.
A peptide is just a short chain of amino acids, the same building blocks your body uses to make protein. Your body already relies on hundreds of its own peptides to run basic functions. Insulin is a peptide. So is oxytocin, the hormone involved in bonding, and the growth hormone that regulates children’s growth. The peptides in current market work by either copying one of these natural signals, boosting it, or blocking one. Once a peptide or a hormone is injected, it activates the specific receptor and all the following cascade downstream functions, in many cases, beyond your desired effect.
When orally taken, our stomach acid and enzymes break down all protein, from a chicken breast to a protein shake, into small pieces of amino acids before they can reach your bloodstream. That’s why insulin has to be injected, not taken orally, and why most other peptides are too.
That’s starting to change. Scientists found a way to create a protective shield around certain peptides as they pass through the stomach, which is what made the Ozempic pill (and now a higher dose tablet for weight loss) possible. It’s a genuine breakthrough, but it isn’t a universal fix. It works because semaglutide happens to be unusually potent and stays active in the body for a long time, so even a small amount getting through is enough. Most peptides don’t have that advantage yet.
If you’re only going to trust one category of peptide, make it this one. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic a hormone your gut releases after eating, one that tells your brain you’re full, slows digestion, and helps your body manage blood sugar. Tirzepatide goes a step further and also mimics a second gut hormone, called GIP, that works alongside the first one to boost insulin release and help the body handle fat and sugar more efficiently. Hitting two signals instead of one is part of why it tends to produce somewhat greater weight loss.
The numbers here are based on large, carefully conducted human trials: average weight loss in the range of 15 to 18% of body weight over a year, plus, for the injectable forms, a proven reduction in cardiovascular events, not just a theoretical benefit. A newer peptide called retatrutide, which targets three hormones at once, is still in trials but has posted the strongest numbers yet. The tradeoff across this whole category is largely digestive: nausea, constipation, and diarrhea, as well as loss of lean mass (muscle, not just fat).
Peptides like CJC-1295, ipamorelin, and sermorelin work by nudging your pituitary gland to release more of your own growth hormone, with the idea being more muscle, better recovery, better sleep, and slower aging. The science behind this is real, as shown in small studies that these peptides raise growth hormone and a related marker called IGF-1.
Where it gets greyer is the leap from “raises a hormone” to “delivers the outcomes people are chasing.” There isn’t solid human trial evidence that this translates into meaningful muscle gain, fat loss, or a slower aging process in otherwise healthy adults. None of these have FDA approval for those purposes, and they’re banned for competitive athletes.
This peptide has been a buzz-word lately. BPC-157 is a small peptide originally isolated from stomach fluid, and it’s marketed for healing tendons, ligaments, and gut tissue faster. The animal research is genuinely interesting. The human research is not up to date. As of this year, there are only a handful of tiny pilot studies, covering fewer than 30 people combined.
That gap is exactly why the FDA banned BPC-157 from compounding pharmacies in 2023, not because it caused harm, but because there wasn’t enough safety data to justify wide use. This is a case where the biological story is attractive and the human evidence simply hasn’t caught up yet.
Most people assume anything for sexual function works the way Viagra does, by affecting blood flow. PT-141 (bremelanotide, brand name Vyleesi) doesn’t. It works in the brain, on the pathways that govern desire itself, which makes it a genuinely different mechanism. It’s approved by the FDA for low sexual desire in premenopausal women, backed by real Phase 3 trials. Nausea is common, and it can cause a temporary, mild bump in blood pressure, which is why it’s not recommended for anyone with uncontrolled hypertension or heart disease.
GLP-1s get full support of evidence-based medicine: multiple trials, FDA approval, real outcomes data. PT-141 seems to have solid proof for its specific, narrow claim. Growth hormone peptides have real biology behind them but not the outcome data people assume exists. BPC-157 is the clearest example of the hype beyond the clinical evidence.
Before I’d consider any peptide for myself or a client, I ask the same questions every time:
What are we doing? What are we trying to achieve? What could be the honest side effect? Do we want to inject ourselves with substances that impact our whole body? Could we achieve the same goal with exercise and a healthier diet?
The peptide wave is real, and some of it is genuinely exciting. But it’s worth stepping back and asking what this trend says about our current society and culture. Instant results are appealing, but most things worth having still take real work: dedication, discipline, time. Not long ago, getting food on the table meant a team of hunters spending days tracking it down. We like to think we’ve evolved past that, but biologically, we haven’t moved nearly as far as our lifestyles have. Our bodies were never built to handle this much abundance, this much food, sugar, and convenience, let alone this much manipulation of our own body by factory-made chemicals. We should try to enjoy the process of what our body is meant to do while filling ourselves with good food, happy thoughts, and motivation.
Author: Nayun Shin is a Doctor of Pharmacy with 10 years of experience in biotech, drug development, and clinical research.

Author
Doctor of Pharmacy
10 years in biotech, drug development & clinical research

It's complicated. That's why Nayun is here.